Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

BBS-Bioactive Bone Substitutes

3.902 følger denne virksomhed
Overview
Investor consensus
Alle
Analyse
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse5.3.2025, 12.30

BBS-Bioactive Bone Substitutes Plc Apply for Delisting from Nasdaq First North

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse20.2.2025, 19.00

BBS-Bioactive Bone Substitutes Plc: Financial calendar and Bankruptcy

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse17.2.2025, 11.15

BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc has been declared bankrupt

BBS-Bioactive Bone Substitutes

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Selskabsmeddelelse12.2.2025, 15.00

BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse10.2.2025, 07.00

BBS-Bioactive Bone Substitutes Plc: Situational information about measures to be taken to secure the company's financial situation and operations

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse6.2.2025, 13.00

BBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse31.1.2025, 14.30

BBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse18.12.2024, 12.00

Correction: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse18.12.2024, 11.00

BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse13.12.2024, 11.00

BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse13.12.2024, 07.30

BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations

BBS-Bioactive Bone Substitutes
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Video2.12.2024, 14.00

Life Science Companies as Investments | Life Science Night Dec. 2, 2024

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Aiforia TechnologiesBBS-Bioactive Bone SubstitutesBioretecBiohitFaron PharmaceuticalsModulightNexstimOrionBittiumDetection TechnologyOptomedRevenio GroupNightingale HealthHerantis PharmaNanoform Finland
Selskabsmeddelelse29.11.2024, 14.30

BBS-Bioactive Bone Substitutes Plc – Insider information: BBS updates its action plans

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse29.11.2024, 14.20

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse29.11.2024, 13.00

BBS-Bioactive Bone Substitutes Plc: Production Director Kimmo Tyni resigns from the Company

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse26.11.2024, 15.00

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse22.11.2024, 17.05

BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse22.11.2024, 17.00

BBS-Bioactive Bone Substitutes Plc – Insider information: BBS will start change negotiations

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse14.11.2024, 12.00

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Selskabsmeddelelse7.11.2024, 11.00

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.